Remember we have a 300 person covid trial running towards 45% for next review. How close that? It was intended MSB add that as a label extension following FDA approval. Surely efficacy data coming through there as well? 90 patients 4, 2020 and New York, USA; September 3, 2020. That started 9 april? How long to process 45 more? How can they deny this? and then 1 month later approve COVID without a label?
Remember we have a 300 person covid trial running towards 45%...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |